Atlas Trials

A DDI Study of FDL169 and FDL176 in Healthy Subjects

Clinical trial NCT03756922 · SUSPENDED

Trial details

NCT number
NCT03756922
Sponsor
Flatley Discovery Lab LLC
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2018-11-27
Primary completion
2020-02-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.